Mainboard · BSE and NSEDraft filed
GAMP Services Limited IPO: dates, price band, lot size, objects of the issue
Get updates on this IPO
Dates, price band, allotment and listing notices by email, and new views from SEBI-registered research analysts on InsightPier by email.Dates, allotment, listing and analyst views. Stop anytime.
By continuing you agree to the Terms and Privacy policy
Key facts
- Price band
- Not announced
- Lot size
- Not announced
- Lot amount at the upper band
- Not announced
- Issue size at the upper band
- 46,93,500 shares (Amount not stated in the draft)
- DRHP dated Sun 18 Oct 2026, page 1
- Bid dates
- Not announced
- Listing date
- Not announced
- Proposed exchanges
- BSE and NSE
Timeline (IST)
- Draft filedWed 21 Oct 2026 confirmedDRHP dated Sun 18 Oct 2026
- OpensDates to be announced
- ClosesDates to be announced
- AllotmentDates to be announced
- Refund and unblockDates to be announced
- ListingDates to be announced
Objects of the issue
| Object | Amount |
|---|---|
| Funding capital expenditure towards purchase of equipment and IT hardware for our Services and Data Logger Manufacturing verticals | ₹40.05 crore |
| Funding inorganic growth through unidentified acquisitions and general corporate purposes | Not stated in the draft |
| Total | Not stated in the draft |
The offer for sale goes to the selling shareholders, not the company. DRHP dated Sun 18 Oct 2026, page 132
Company and promoters
As described in the DRHP
We are a compliance and validation company providing validation, qualification and instrumentation solutions to customers operating primarily in regulated industries. Our services support customers in establishing, qualifying, operating and maintaining manufacturing facilities, utilities, equipment and computerised systems in accordance with applicable regulatory and quality requirements.
DRHP dated Sun 18 Oct 2026, page 240
Promoters
- 3 individual promoters
DRHP dated Sun 18 Oct 2026, page 321
Shareholding
| Holding | Before the issue | After the issue |
|---|---|---|
| Promoters and promoter group | 99.99% | Not stated in the DRHP |
DRHP dated Sun 18 Oct 2026, page 121
Who is selling in the offer for sale
| Selling shareholder | Type | Shares offered | Amount at the upper band |
|---|---|---|---|
| Individual shareholder | Individual | 6,20,700 | Not announced |
| Individual shareholder | Individual | 6,20,700 | Not announced |
| Individual shareholder | Individual | 2,58,600 | Not announced |
| Total offer for sale | Not announced | ||
DRHP dated Sun 18 Oct 2026, page 1
Risk factors
80 total- Most revenue comes from life sciences customers, mainly pharmaceutical companies (DRHP page 32)
- Heavy reliance on the services vertical; lower demand for validation services could hurt results (DRHP page 34)
- Most purchases come from foreign suppliers, exposing the company to supply chain disruption (DRHP page 35)
- Purchases are concentrated among the top ten suppliers (DRHP page 36)
- Exchange rate movements may affect the value of the shares (DRHP page 89)